Frequently Asked Questions
The global Direct to Consumer Microbiome Analyzing market is expected to be impacted significantly by COVID-19.
North America accounted for the highest share in the global Direct to Consumer Microbiome Analyzing market in terms of value.
The increasing frequency of genetic illnesses, as well as many applications of direct to consumer microbiome analysis in primary identification of oncology, chronic diseases, infections, and other genetic disorders, will drive market growth. The rising prevalence of chronic diseases and gut infections has increased the global revenue of microbiome testing kits, propelling the Direct to Consumer Microbiome Analysis market forward.
Gut microbiome test kits segment had a major share in 2021 with more than 40% of the market revenue share.
Gut conditions segment had a major share in 2021 with more than 30% of the market revenue share.